Leo J. Schep

2.2k total citations
35 papers, 1.4k citations indexed

About

Leo J. Schep is a scholar working on Emergency Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Leo J. Schep has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Emergency Medicine, 8 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Leo J. Schep's work include Poisoning and overdose treatments (10 papers), Forensic Toxicology and Drug Analysis (5 papers) and Antifungal resistance and susceptibility (3 papers). Leo J. Schep is often cited by papers focused on Poisoning and overdose treatments (10 papers), Forensic Toxicology and Drug Analysis (5 papers) and Antifungal resistance and susceptibility (3 papers). Leo J. Schep collaborates with scholars based in New Zealand, United Kingdom and Sweden. Leo J. Schep's co-authors include Robin J Slaughter, D. Michael G. Beasley, Wayne A. Temple, Allister Vale, Gordon Becket, J Allister Vale, Martin Watts, Paul Gee, Bruno Mégarbane and Kai Knudsen and has published in prestigious journals such as Journal of Controlled Release, Environment International and International Journal of Pharmaceutics.

In The Last Decade

Leo J. Schep

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leo J. Schep New Zealand 19 249 243 217 172 155 35 1.4k
Yvan Gaillard France 23 510 2.0× 281 1.2× 233 1.1× 129 0.8× 158 1.0× 86 1.7k
Sotiris Athanaselis Greece 25 705 2.8× 290 1.2× 208 1.0× 224 1.3× 235 1.5× 110 2.1k
Min Shen China 22 659 2.6× 290 1.2× 134 0.6× 136 0.8× 225 1.5× 93 1.3k
Lucia Pötsch Germany 23 767 3.1× 153 0.6× 99 0.5× 140 0.8× 175 1.1× 50 1.3k
Robin J Slaughter New Zealand 14 222 0.9× 156 0.6× 194 0.9× 165 1.0× 120 0.8× 25 1.0k
Ian R. Tebbett United States 22 263 1.1× 175 0.7× 49 0.2× 145 0.8× 43 0.3× 76 1.3k
A. Robert Jeffcoat United States 24 542 2.2× 433 1.8× 72 0.3× 588 3.4× 148 1.0× 42 2.4k
C. Locatelli Italy 26 154 0.6× 411 1.7× 139 0.6× 153 0.9× 74 0.5× 136 1.6k
J Allister Vale United Kingdom 21 240 1.0× 272 1.1× 780 3.6× 104 0.6× 114 0.7× 50 2.3k
Diana Dias da Silva Portugal 23 458 1.8× 308 1.3× 36 0.2× 284 1.7× 294 1.9× 62 1.4k

Countries citing papers authored by Leo J. Schep

Since Specialization
Citations

This map shows the geographic impact of Leo J. Schep's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo J. Schep with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo J. Schep more than expected).

Fields of papers citing papers by Leo J. Schep

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo J. Schep. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo J. Schep. The network helps show where Leo J. Schep may publish in the future.

Co-authorship network of co-authors of Leo J. Schep

This figure shows the co-authorship network connecting the top 25 collaborators of Leo J. Schep. A scholar is included among the top collaborators of Leo J. Schep based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo J. Schep. Leo J. Schep is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schep, Leo J., Robin J Slaughter, & David McBride. (2013). Riot control agents: the tear gases CN, CS and OC—a medical review. Journal of the Royal Army Medical Corps. 161(2). 94–99. 37 indexed citations
2.
Beasley, D. Michael G., Leo J. Schep, Robin J Slaughter, Wayne A. Temple, & Jonathan Michel. (2013). Full Recovery from a Potentially Lethal Dose of Mercuric Chloride. Journal of Medical Toxicology. 10(1). 40–44. 22 indexed citations
3.
Schep, Leo J., Kai Knudsen, Robin J Slaughter, J Allister Vale, & Bruno Mégarbane. (2012). The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clinical Toxicology. 50(6). 458–470. 124 indexed citations
4.
Schep, Leo J., Robin J Slaughter, J Allister Vale, D. Michael G. Beasley, & Paul Gee. (2011). The clinical toxicology of the designer “party pills” benzylpiperazine and trifluoromethylphenylpiperazine. Clinical Toxicology. 49(3). 131–141. 58 indexed citations
5.
Schep, Leo J., Robin J Slaughter, & D. Michael G. Beasley. (2010). The clinical toxicology of metamfetamine. Clinical Toxicology. 48(7). 675–694. 110 indexed citations
6.
Schep, Leo J., et al.. (2009). Ricin as a weapon of mass terror — Separating fact from fiction. Environment International. 35(8). 1267–1271. 53 indexed citations
7.
Schep, Leo J., Robin J Slaughter, Gordon Becket, & D. Michael G. Beasley. (2009). Poisoning due to water hemlock. Clinical Toxicology. 47(4). 270–278. 43 indexed citations
8.
Schep, Leo J., Robin J Slaughter, Wayne A. Temple, & D. Michael G. Beasley. (2009). Diethylene glycol poisoning. Clinical Toxicology. 47(6). 525–535. 122 indexed citations
9.
Schep, Leo J., Robin J Slaughter, J Allister Vale, & D. Michael G. Beasley. (2009). A seaman with blindness and confusion. BMJ. 339(sep30 1). b3929–b3929. 13 indexed citations
10.
Schep, Leo J., et al.. (2009). The adverse effects of hydrogen cyanamide on human health: an evaluation of inquiries to the New Zealand National Poisons Centre. Clinical Toxicology. 47(1). 58–60. 16 indexed citations
11.
Schep, Leo J., Robin J Slaughter, & D. Michael G. Beasley. (2009). Nicotinic plant poisoning. Clinical Toxicology. 47(8). 771–781. 80 indexed citations
12.
Schep, Leo J., et al.. (2006). Veratrum Poisoning. PubMed. 25(2). 73–78. 41 indexed citations
13.
Watts, Martin, John Fountain, David Reith, & Leo J. Schep. (2004). Compliance with Poisons Center Referral Advice and Implications for Toxicovigilance. Journal of Toxicology Clinical Toxicology. 42(5). 603–610. 14 indexed citations
14.
Becket, Gordon, et al.. (1999). Improvement of the in vitro dissolution of praziquantel by complexation with α-, β- and γ-cyclodextrins. International Journal of Pharmaceutics. 179(1). 65–71. 111 indexed citations
15.
Schep, Leo J., Ian G. Tucker, G. Young, Robin Ledger, & Grant Butt. (1999). Controlled release opportunities for oral peptide delivery in aquaculture. Journal of Controlled Release. 59(1). 1–14. 21 indexed citations
16.
Schep, Leo J., Ian G. Tucker, G. Young, Robin Ledger, & Grant Butt. (1998). Permeability of the salmon ( Oncorhynchus tshawytscha ) posterior intestine in vivo to two hydrophilic markers. Journal of Comparative Physiology B. 168(8). 562–568. 9 indexed citations
17.
Jones, David S., Leo J. Schep, & M G Shepherd. (1995). The Effects of Cetylpyridinium Chloride on the Cell Surface Charge (Zeta Potential) of Candida albicans: Implications for Anti‐adherence Effects. Pharmacy and Pharmacology Communications. 1(11). 513–515. 6 indexed citations
18.
Schep, Leo J., David S. Jones, & M G Shepherd. (1995). Primary Interactions of Three Quaternary Ammonium Compounds with Blastospores of Candida albicans (MEN Strain). Pharmaceutical Research. 12(5). 649–652. 15 indexed citations
19.
Jones, David S., Leo J. Schep, & M G Shepherd. (1995). The Effect of Cetylpyridinium Chloride (CPC) on the Cell Surface Hydrophobicity and Adherence of Candida albicansto Human Buccal Epithelial Cells in Vitro. Pharmaceutical Research. 12(12). 1896–1900. 25 indexed citations
20.
Schep, Leo J., et al.. (1994). A method to study the adherence of Candida albicans to human buccal epithelial cells in vitro using 35SO4 radiolabelled blastospores and a PercollTM gradient. International Journal of Pharmaceutics. 105(1). 39–45. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026